Inventor · disambiguated record
Maxence Bos
Also filed as: BOS MAXENCE · BOS MAXENCE BENJAMIN
4 granted patents·6 pending applications·10 citations·filing 2020–2025
70Inventor score
Top patents by PatentIndex Score
10 records- 0194US11608344B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2021·Granted Mar 21, 2023·4 cites·30 claims
- 0293US11912711B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2022·Granted Feb 27, 2024·3 cites·30 claims
- 0393US11884675B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2022·Granted Jan 30, 2024·3 cites·30 claims
- 0482US12428425B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2023·Granted Sep 30, 2025·0 cites·18 claims
- 0567US2025042897A1Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useVIGIL NEUROSCIENCE INC·Filed 2022·Application pending·0 cites
- 0661US2025051294A1Method for preparing cyclohexyl thiazolyl phenyl carbamateCYTEIR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0759US2025304580A1Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useVIGIL NEUROSCIENCE INC·Filed 2025·Application pending·0 cites
- 0856US2024309003A1Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useVIGIL NEUROSCIENCE INC·Filed 2022·Application pending·0 cites
- 0947US2023234967A1Fused Azole Heterocycles as AHR AntagonistsSENDA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1044US2023295152A1Pyridopyrimidinone derivatives as ahr antagonistsSENDA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maxence Bos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →